tumor
Conditions
Interventions
Uygur medicine:Abnormal Savda mature 30-45 days and scavenger 3-5 days
control:placebo
Non abnormal savda mature (None random):routine
Healthy (none random):NA
Sponsors
The Fourth Affiliated Hospital of Xinjiang Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18-75 years, Conforming to malignant tumor diagnostic criteria, and with clear pathology diagnosed; 2. Complete relevant operation, radiotherapy, chemotherapy, intervention therapy 2 weeks before entering the group in line with disease treatment principle; 3. KPS score >= 60; 4. Expected survival for more than 6 months; 5. Signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients without pathological diagnosed; 2. Patients with cardiovascular and cerebrovascular diseases or serious mental disorders and other similar diseases, or patients with combined active tuberculosis and severe infectious diseases; 3. Patients with severe liver or kidney dysfunction;or patients with severe bleeding tendency; 4. Age under 18 or beyond 75 years; 5. Pregnant or lactating women; 6. Allergy to drugs used in this study; 7. Poor nutrition, KPS score < 60; 8. Also received other antineoplastic therapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| proteomic indexes;metabonomic index; | — |
Countries
China
Contacts
Public ContactHalmurat.Upur
The fourth affiliated hospital of Xinjiang medical University
Outcome results
None listed